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Since it was ﬁrst described approximately 15 years ago, the Brugada Syndrome has spurred a signiﬁcant quantity of interest
in its underlying mechanism and physiology. The Brugada electrocardiographic pattern is characterized by right bundle
branch block morphology and ST segment elevations in the right precordial leads with an absence of identiﬁable underlying
structural heart disease. The syndrome is clinically signiﬁcant since these patients are at a higher risk of developing malignant
ventricular arrhythmias. One of the mechanisms behind the disorder involves mutations in speciﬁc myocardial sodium channels.
Furthermore, these electrocardiographic changes appear to be temperature dependent. We present the case of a 35-year-old male
who presented with intestinal Shigellosis and was also found to have Brugada-type electrocardiographic changes on ECG. The
electrocardiographic changes that were present when the patient was admitted and febrile resolved following antibiotic therapy
and defervescence.
Copyright © 2009 John N. Makaryus et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Case Presentation
A 37-year-old man with a history of mitral valve prolapse
presented to the emergency department (ED) with a two-
day history of fevers (up to 105◦ Fahrenheit (F) at home)
and twelve episodes of grossly bloody diarrhea, which began
approximately two hours after eating take-out Chinese food.
The patient also reported dizziness and lightheadedness
upon standing, likely secondary to dehydration from signiﬁ-
cant quantities of diarrhea.
In the ED, the patient was febrile with a temperature of
103.5◦F,tachycardicwithaheartrateof114beatsperminute,
and orthostatic, but was otherwise hemodynamically stable.
Laboratorystudieswereunremarkable.Inadditiontoaggres-
siveintravenous(IV)hydration,thepatientwasstartedonIV
ciproﬂoxacinandmetronidazolefortheempirictreatmentof
bacterial gastroenteritis. Although blood and urine cultures
were negative, the patient’s stool culture found moderate
Shigella sonnei. The patient’s diarrhea gradually resolved
followinginitiationofIVantibioticsandhewassubsequently
discharged on oral ciproﬂoxacin to complete a seven-day
course of therapy.
On admission, a routine electrocardiogram (Figure 1)
incidentally demonstrated an incomplete right bundle
branch block along with 1.5mm ST segment elevations with
descent into inverted T waves in leads V1 and V2. On
hospital day 1, a repeat ECG demonstrated similar ﬁndings.
A subsequent ECG on hospital day 2 (Figure 2), when the
patient was afebrile, demonstrated resolution of the previ-
ously seen electrocardiographic ﬁndings and restoration of a
regularsinusbradycardia.Detailedquestioningofthepatient
(and his mother) revealed that there was no reported family
history of sudden cardiac death or known arrhythmias. The
patient’s father did have coronary artery disease and had
undergone percutaneous coronary intervention at the age of
67. Otherwise, neither the patient nor his family members
had ever heard of the term “Brugada” and were not aware
of any other signiﬁcant family history of cardiac disease.
The patient himself had reportedly had an episode where he
“passed out” approximately eight years prior to presentation2 Case Reports in Medicine
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Figure 1: ECG upon admission demonstrating ST-segment elevations in leads V1 and V2 and incomplete right-bundle-branch block
pattern, ﬁndings consistent with Brugada type 1 pattern. The patient was febrile to 103◦F when this ECG was performed.
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Figure 2: The patient’s ECG on hospital day 2 after he had been treated with intravenous antibiotics and had defervesced. The ECG
demonstrates minor ST changes but resolution of the ﬁndings seen up on admission.
and had a reportedly normal electrocardiogram and an
echocardiogram which demonstrated mitral valve prolapse
but was otherwise unremarkable. He stated that his doctor
at the time told him that he was likely dehydrated. The
patient otherwise denied any chronic chest pain, shortness-
of-breath, palpitations, or any limitation of his exercise
tolerance. Given the lack of cardiovascular symptoms during
the current episode and resolution of previously seen ECG
ﬁndings after defervescence, the patient was discharged. He
followed up with an electrophysiologist following discharge
and had a repeat ECG which was unremarkable. He opted
not to pursue any further testing but will follow regularly
with his outpatient physician for followup of his abnormal
ECG.Case Reports in Medicine 3
2. Discussion
The patient clearly suﬀered from gastrointestinal shigellosis
given the presence of crampy abdominal pain, bloody
diarrhea, and stool studies that positively identiﬁed the
organism. The microorganism was sensitive to ciproﬂoxacin
and the patient showed signs of clinical improvement
relatively quickly after initiation of therapy. The electrocar-
diographicﬁndings,however,quicklybecamethefocusofhis
care.
The electrocardiographic ﬁndings present on the ﬁrst
ECG are consistent with the Brugada pattern. The Brugada
syndrome is divided into three types based upon the
morphology of the electrocardiographic changes. Type 1 is
characterized by coved ST-segment elevations in the right
precordial leads followed by T-wave inversions. The ST
elevations in type 2 Brugada syndrome are usually described
as having a “saddleback” appearance with a high takeoﬀ
ST-segment elevation followed by a trough with a less
pronounced ST elevation and a subsequent biphasic or
positive T wave. The third and ﬁnal Brugada pattern has ST
elevations with either a coved or saddleback appearance with
ST-segment elevations of 1 mm [1].
The ECG in the case presented above demonstrates type
1 Brugada morphology with coved ST-segment elevations in
leads V1-V2 followed by T-wave inversions. Furthermore,
in this case, the diagnosis is clinched by the clinical
circumstances in which the electrocardiographic ﬁndings
were appreciated. The Brugada syndrome is deﬁned as RBBB
pattern (really J-point elevation) with ST-segment eleva-
tions in leads V1-V3 and syncope, documented ventricular
ﬁbrillation, sudden cardiac death (SCD) in a patient with
a structurally normal heart, or a family history of sudden
cardiac death in a family member less than 45 years of age
[1]. In addition, the electrocardiographic ﬁndings associated
with Brugada syndrome can often be elicited by sodium
channel blockers, vagotonic agents, or by a febrile illness, as
was most likely the case here [2–5].
The etiology of the Brugada syndrome has been inves-
tigated extensively over the past ﬁfteen years. Data suggest
a likely genetic predisposition stemming from mutations in
the genes encoding speciﬁc subunits of myocardial sodium
channels [6]. Approximately 25% of all Brugada patients
have been shown to have a mutation in the cardiac sodium
channel gene SCN5A located on chromosome 3. Other
genetic mutations, including alterations of the β-subunit
of cardiac sodium channels, may also be associated with a
greater risk of arrhythmogenicity and Brugada syndrome.
Anything that alters inﬂow or outﬂow through these sodium
channels, including elevated core body temperature, may
unmasktheelectrocardiographicﬁndingsassociatedwiththe
Brugada syndrome [3, 5, 7]. As a result, in some patients,
theBrugadasyndromemayonlybediscoveredwhenthecore
body temperature is elevated. While individuals with febrile
illness may be predisposed to syncope as a result of potential
orthostatic hypotension or vasovagal syncope which are
far more common than arrhythmogenic causes of syncope,
physicians should be aware of the association between fever
and the Brugada syndrome. However, the prognostic value
of Brugada morphology ECG changes observed only during
a febrile illness remains unknown.
The Brugada syndrome is estimated to account for
almost ﬁve percent of all sudden cardiac deaths and about
a ﬁfth of all deaths in patients with no evidence of structural
cardiac abnormalities [8]. As a result, careful electrocardio-
graphic analysis, even in individuals not suspected of having
cardiovascular disease, is essential. The only proven eﬀective
treatment option for patients with the Brugada syndrome
is the implantable cardioverter-deﬁbrillator (ICD) [9, 10].
There are several speciﬁc indications for ICD implantation,
including the presence of type 1 Brugada electrocardio-
graphic pattern in the presence of symptoms (such as
syncope, seizure, or nocturnal agonal respiration). Asymp-
tomatic patients usually undergo electrophysiology studies
(EPS) prior to ICD implantation. Even if asymptomatic,
patients with the Brugada-type electrocardiographic pattern
should be further evaluated. The utility of EPS for risk
stratiﬁcation has been debated, and the optimal means of
identifying high-risk patients remains uncertain.
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